Dr Catalina Lopez-Correa, MD PhD

Driving Clinical Implementation of Genomics in British Columbia


With more than 20 years of international experience in both the academic and private sectors, Dr. Catalina Lopez-Correa’s deep understanding of genomics has inspired leaders in science and industry to collaborate toward solving some of the world’s greatest challenges.

Prior to joining Genome BC, Catalina was the CSO and Vice-President Scientific Affairs at Genome Quebec, where she was instrumental in developing competitive teams for national and provincial research projects raising the profile of Canadian genomics on the global stage. 
Before becoming one of Canada’s leading advocates for genomics research and translation, Catalina held senior research positions with pharmaceutical giant Eli Lilly and the renowned deCODE genetics lab in Iceland. From leading teams to identifying genomic biomarkers in therapeutic areas of oncology, cardio-metabolic and neurosciences to developing screening strategies associated with disease, Catalina’s leadership helped drive the discovery and development pipelines.
As part of her commitment to international development, Catalina has championed several initiatives aimed at demonstrating the impact of genomics in developing countries. Since 2002 she has served as evaluator for large multinational projects funded by the European Commission and has been recognized with several awards nationally and internationally.
Catalina holds a Medical degree from the UPB in Colombia, a Master’s degree in Human Genetics from Paris V University in France, a PhD in Medical Sciences from the KULeuven in Belgium, and a mini MBA from McGill University in Canada.
2013: National order of Merit Award in the Rank of Officer. Appointed by the Honorable President of the Republic of Colombia, Juan Manuel Santos Calderon. This honorable distinction is conferred to Dr. Lopez-Correa for her outstanding professional and academic career and the scientific contributions in the field of Genomics in Canada